Global β-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 105
Published Date: 28 Apr 2024
Category: Chemical & Material
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
According to our (Global Info Research) latest study, the global β-Nicotinamide Mononucleotide (NMN) market size was valued at US$ 371 million in 2023 and is forecast to a readjusted size of USD 774 million by 2030 with a CAGR of 10.6% during review period.
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ≥98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report is a detailed and comprehensive analysis for global β-Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global β-Nicotinamide Mononucleotide (NMN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global β-Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for β-Nicotinamide Mononucleotide (NMN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global β-Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
β-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Content ≥98%
Content ＜98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe β-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of β-Nicotinamide Mononucleotide (NMN), with price, sales quantity, revenue, and global market share of β-Nicotinamide Mononucleotide (NMN) from 2019 to 2024.
Chapter 3, the β-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and β-Nicotinamide Mononucleotide (NMN) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of β-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe β-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Content ≥98%
1.3.3 Content ＜98%
1.4 Market Analysis by Application
1.4.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2030)
1.5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price (2019-2030)
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Mirailab Bioscience
2.4.1 Mirailab Bioscience Details
2.4.2 Mirailab Bioscience Major Business
2.4.3 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Mirailab Bioscience Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Kingdomway Recent Developments/Updates
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024)
3.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
3.4.3 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
3.5 β-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 β-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
4.1.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2030)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
4.6 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2030)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030)
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2030)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030)
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of β-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of β-Nicotinamide Mononucleotide (NMN)
13.3 β-Nicotinamide Mononucleotide (NMN) Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GeneHarbor Basic Information, Manufacturing Base and Competitors
Table 4. GeneHarbor Major Business
Table 5. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 6. GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GeneHarbor Recent Developments/Updates
Table 8. Herbalmax Basic Information, Manufacturing Base and Competitors
Table 9. Herbalmax Major Business
Table 10. Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 11. Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Herbalmax Recent Developments/Updates
Table 13. Genex Formulas Basic Information, Manufacturing Base and Competitors
Table 14. Genex Formulas Major Business
Table 15. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 16. Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Genex Formulas Recent Developments/Updates
Table 18. Mirailab Bioscience Basic Information, Manufacturing Base and Competitors
Table 19. Mirailab Bioscience Major Business
Table 20. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 21. Mirailab Bioscience β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Mirailab Bioscience Recent Developments/Updates
Table 23. Maac10 Formulas Basic Information, Manufacturing Base and Competitors
Table 24. Maac10 Formulas Major Business
Table 25. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 26. Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Maac10 Formulas Recent Developments/Updates
Table 28. EffePharm Basic Information, Manufacturing Base and Competitors
Table 29. EffePharm Major Business
Table 30. EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 31. EffePharm β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. EffePharm Recent Developments/Updates
Table 33. Bontac Basic Information, Manufacturing Base and Competitors
Table 34. Bontac Major Business
Table 35. Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 36. Bontac β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Bontac Recent Developments/Updates
Table 38. CELFULL Basic Information, Manufacturing Base and Competitors
Table 39. CELFULL Major Business
Table 40. CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 41. CELFULL β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. CELFULL Recent Developments/Updates
Table 43. Kingdomway Basic Information, Manufacturing Base and Competitors
Table 44. Kingdomway Major Business
Table 45. Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
Table 46. Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Kingdomway Recent Developments/Updates
Table 48. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024) & (Tons)
Table 49. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 51. Market Position of Manufacturers in β-Nicotinamide Mononucleotide (NMN), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 52. Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site of Key Manufacturer
Table 53. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
Table 54. β-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
Table 55. β-Nicotinamide Mononucleotide (NMN) New Market Entrants and Barriers to Market Entry
Table 56. β-Nicotinamide Mononucleotide (NMN) Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 58. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2024) & (Tons)
Table 59. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2025-2030) & (Tons)
Table 60. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2025-2030) & (USD Million)
Table 62. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2024) & (US$/Kg)
Table 63. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Region (2025-2030) & (US$/Kg)
Table 64. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 65. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 66. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2024) & (USD Million)
Table 67. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2025-2030) & (USD Million)
Table 68. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2024) & (US$/Kg)
Table 69. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2025-2030) & (US$/Kg)
Table 70. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 71. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 72. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2024) & (US$/Kg)
Table 75. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2025-2030) & (US$/Kg)
Table 76. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 77. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 78. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 79. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 80. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
Table 81. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
Table 82. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 85. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 86. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 87. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 88. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
Table 89. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
Table 90. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
Table 91. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 93. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 94. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 95. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 96. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2024) & (Tons)
Table 97. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2025-2030) & (Tons)
Table 98. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2025-2030) & (USD Million)
Table 100. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 101. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 102. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 103. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 104. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
Table 105. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
Table 106. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2024) & (Tons)
Table 109. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2025-2030) & (Tons)
Table 110. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2024) & (Tons)
Table 111. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2025-2030) & (Tons)
Table 112. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2024) & (Tons)
Table 113. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2025-2030) & (Tons)
Table 114. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2025-2030) & (USD Million)
Table 116. β-Nicotinamide Mononucleotide (NMN) Raw Material
Table 117. Key Manufacturers of β-Nicotinamide Mononucleotide (NMN) Raw Materials
Table 118. β-Nicotinamide Mononucleotide (NMN) Typical Distributors
Table 119. β-Nicotinamide Mononucleotide (NMN) Typical Customers
List of Figures
Figure 1. β-Nicotinamide Mononucleotide (NMN) Picture
Figure 2. Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type in 2023
Figure 4. Content ≥98% Examples
Figure 5. Content ＜98% Examples
Figure 6. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 8. Health Care Products Examples
Figure 9. Cosmetics Examples
Figure 10. Others Examples
Figure 11. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2030) & (Tons)
Figure 14. Global β-Nicotinamide Mononucleotide (NMN) Price (2019-2030) & (US$/Kg)
Figure 15. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of β-Nicotinamide Mononucleotide (NMN) by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 18. Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2023
Figure 19. Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer (Revenue) Market Share in 2023
Figure 20. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2019-2030)
Figure 22. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 25. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 27. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Type (2019-2030)
Figure 29. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030) & (US$/Kg)
Figure 30. Global β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global β-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2030)
Figure 32. Global β-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030) & (US$/Kg)
Figure 33. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
Figure 37. United States β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 45. France β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Region (2019-2030)
Figure 53. China β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 56. India β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 59. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales Quantity Market Share by Country (2019-2030)
Figure 68. Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 70. Egypt β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 71. Saudi Arabia β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 72. South Africa β-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030) & (USD Million)
Figure 73. β-Nicotinamide Mononucleotide (NMN) Market Drivers
Figure 74. β-Nicotinamide Mononucleotide (NMN) Market Restraints
Figure 75. β-Nicotinamide Mononucleotide (NMN) Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of β-Nicotinamide Mononucleotide (NMN) in 2023
Figure 78. Manufacturing Process Analysis of β-Nicotinamide Mononucleotide (NMN)
Figure 79. β-Nicotinamide Mononucleotide (NMN) Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GeneHarbor Herbalmax Genex Formulas Mirailab Bioscience Maac10 Formulas EffePharm Bontac CELFULL Kingdomway
Related Reports
29 Jun 2023
Chemical & Material
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
